Search

Author/Creator Wilke, C

1. 153OResponse rate by geographic region in patients with hormone receptor-positive, human epidermal growth factor receptor-2–negative advanced breast cancer from the SOLAR-1 trial. (13th May 2019)

Authors:
Loibl, S; Conte, P F; Campone, M; Mayer, I; Lu, Y-S; Denduluri, N; Wilke, C; Ridolfi, A; André, F
Journal:
Annals of oncology
Issue:
Volume 30(2019)Supplement 3
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. LBA3_PRAlpelisib (ALP) + fulvestrant (FUL) for advanced breast cancer (ABC): Results of the phase III SOLAR-1 trial. (23rd October 2018)

Authors:
André, F; Ciruelos, E M; Rubovszky, G; Campone, M; Loibl, S; Rugo, H S; Iwata, H; Conte, P; Mayer, I A; Kaufman, B; Yamashita, T; Lu, Y -S; Inoue, K; Takahashi, M; Pápai, Z; Longin, A-S; Mills, D; Wilke, C; Hirawat, S; Juric, D
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗